Where is Shifamed's headquarters located?

Shifamed's headquarters is located in Campbell (United States).

How many companies has Shifamed invested in?

Shifamed has invested in 12 companies, including Supira Medical & Atia Vision.

Which companies has Shifamed invested in lately?

Supira Medical & Akura Medical are the latest investments by Shifamed.

How many exits has Shifamed been involved in?

Shifamed's portfolio has seen 4 acquisitions.

Shifamed - 2026 Investor Profile, Portfolio, Team & Investment Trends

Shifamed, an accelerator and incubator program founded in 2007, is based in Campbell, United States. With a presence in 1 country, it has supported around 12 startups in sectors like Life Sciences, HealthTech. As of Oct 2026, Shifamed has witnessed 4 portfolio exits. Most notable companies in its portfolio include Supira Medical, Atia Vision and Myra Vision. The program is backed by a team of 3 people who primarily support Series B startups based in United States. Its latest investment was a $40M Series D round in Supira Medical on Nov 17, 2023, which also saw participation from Cormorant Asset Management and The Capital Partnership.

Key Metrics

Founded Year

2007

Location

Campbell, United States

Portfolio Companies

Supira Medical, Atia Vision & 10 more

Sectors of Investment

Life Sciences, HealthTech & 1 more

Stages of Investment

Series A, Series B & 1 more

Locations of Investment

United States

View Shifamed's full profile

Shifamed has a portfolio of 12 companies. Their most notable investments include Supira Medical and Atia Vision.Their portfolio spans across and United States. They have invested in Life Sciences, HealthTech, Enterprise Applications, across Series A, Series B and 1 more. Here is the list of top investments by Shifamed:

1. Supira Medical

Developer of ventricular assist devices for coronary intervention and cardiogenic shock. The company has developed solutions for temporary mechanical circulatory support percutaneous ventricular assist devices. It has a feature that maintains the native pumping action of the heart. It provides real-time data about pump performance and location and minimizes vascular complications for patients with coronary artery disease.

Key facts about Supira Medical

Founded Year: 2016
Location: Campbell (United States)
Stage: Series E
Total Funding till date: $240M
Employee Count: 143 as on Sep 30, 2026
Investors: Qatar Investment Authority, Techlink Ventures and 9 Others
Latest Funding Round: Series E, Mar 25, 2025, $*****
Highlight: Editors' Pick

2. Atia Vision

Atia Vision has developed a presbyopia-correcting intraocular lens to restore vision in cataract patients. The presbyopia-correcting IOL responds to the ciliary muscles to behave like the natural eye lens to restore the vision in cataract individuals.

Key facts about Atia Vision

Founded Year: 2012
Location: Campbell (United States)
Stage: Series E
Total Funding till date: $67M
Employee Count: 15 as on Sep 30, 2026
Investors: Cormorant-asset, Cormorant Asset Management and 7 Others
Latest Funding Round: Series E, Aug 02, 2022, $*****

3. Myra Vision

Developer of a medical device for the treatment of glaucoma. The company's nanotechnology-based device allows the reduction of intraocular pressure for the treatment of moderate to severe glaucoma patients.

Key facts about Myra Vision

Founded Year: 2019
Location: Campbell (United States)
Stage: Series B
Total Funding till date: $42M
Employee Count: 22 as on Aug 31, 2026
Investors: Cormorant Asset Management, Cormorant Capital and 5 Others
Latest Funding Round: Series B, Jun 26, 2023, $*****
Highlight: Editors' Pick

4. Laza Medical

AI-powered robotically-assisted imaging solutions for cardiovascular interventions. The company offers imaging solution for cardiovascular interventions to enable imaging and advanced procedure navigation for a wide population of clinicians.

Key facts about Laza Medical

Founded Year: 2022
Location: Los Gatos (United States)
Stage: Series A
Total Funding till date: $36M
Employee Count: 35 as on Aug 31, 2026
Investors: Shifamed, GE HealthCare and 5 Others
Latest Funding Round: Series A, Nov 24, 2023, $*****
Highlight: Editors' Pick

5. Adona Medical

Developer of medical devices for the management of heart failure. It is developing next-generation of interatrial shunting and hemodynamic sensors to address patients with heart failure.

Key facts about Adona Medical

Founded Year: 2017
Location: Campbell (United States)
Stage: Series C
Total Funding till date: $71M
Employee Count: 24 as on Aug 31, 2026
Investors: Shifamed, AMED Ventures and 7 Others
Latest Funding Round: Series C, Jun 27, 2024, $*****
Highlight: Editors' Pick

View the full list of portfolio companies

Shifamed has invested in 13 companies over the last 8 years, with an average of 1 new investment annually in the last 5 years. Its most recent first time investment was in Atia Vision and most recent follow-on round was in Supira Medical.

Here are Shifamed's Year-on-Year Investment Trends:

Year	No. of Investments
Year	1^st Round	Follow-on	Total
2026 (YTD)	0	0	0
2025	0	0	0
2024	0	0	0
2023	0	3	3
2022	3	1	4
2021	2	0	2
2020	0	1	1
2019	0	0	0
2018	1	0	1

View all investments by Shifamed

Shifamed has made 3 investments in Series A stage with an average round size of $19.2M, 2 investments in Series B stage with an average round size of $33.8M and 1 investment in Series E stage with an average round size of $42M.

Here are Shifamed's investments by stage:

Stage of entry	No. of Investments
Series A	3
Series B	2
Series E	1

Note: We have considered here, only first round of investments

View all investments by Shifamed

Shifamed has a portfolio focused on Life Sciences. Notably, it has invested in 12 Tech companies, 10 Enterprise (B2B) companies, 8 Tech hardware companies and at least 3 companies focusing on Software.

View all investments by Shifamed

Shifamed has made most investments in United States (6).

View all investments by Shifamed

Shifamed has not made any investment in 2026 so far.

Here are the most recent investments by Shifamed:

Filter this list

Date	Company	Location	Round Details	Round Amount	Co-Investors
Nov 17, 2023	Supira Medical	United States	Series D	8301	Cormorant Asset Management ... [+5]
Oct 03, 2023	Akura Medical	United States	Series B	1561	The Capital Partnership [+5]
Feb 09, 2023	Tioga Cardiovascular	United States	Series C	1890	The Capital Partnership [+3]
Aug 02, 2022	Atia Vision	United States	Series E	3315	Cormorant Asset Management ... [+3]
Apr 29, 2022	Adona Medical	United States	Series B	5524	AMED Ventures [+3]

See more recent investments made by Shifamed

4 companies from Shifamed's portfolio have been acquired. The most recent acquisition was Apama Medical in Oct 2017 by Boston Scientific for $*****.

Here are Shifamed's portfolio companies that got acquired most recently:

Filter this list

Company	Acquisition Date	First Invested on	First Round of Investment	Round Size
Apama Medical	Oct 02, 2017	-	-	9579
Kalila Medical	Feb 02, 2016	-	-	1465
Maya Medical	May 08, 2012	-	-	3755
Sadra Medical	Nov 19, 2010	-	-	5065

View all acquired companies in Shifamed's portfolio

Shifamed has a team of 3 members including 1 Partner and 1 Principal located in United States. Shifamed's team does not sit on the board of any company as of now.

View team details of Shifamed

Over the past 8 years, 25 investors have co-invested in Shifamed's portfolio companies. This includes only funds.

Invested before Shifamed: The Capital Partnership, ShangBay Capital and 3 others have invested in rounds before Shifamed. There are 2 companies where The Capital Partnership has invested before Shifamed and 2 companies where ShangBay Capital has invested before Shifamed.
Top Co-investors of Shifamed: 8 investors entered a company along with Shifamed. These include investors like The Capital Partnership (4 companies).
Invested after Shifamed: A total of 12 investors have invested in Shifamed's portfolio after their investments. Top Investors include PA MedTech VC Fund (4 companies) and Unorthodox Ventures (3 companies).